NCT03252938 2026-02-19INSIGHTInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 1 Active not recruiting83 enrolled
NCT03558139 2024-04-01Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum ChemotherapyGilead SciencesPhase 1 Completed34 enrolled 17 charts
NCT03861403 2023-11-30A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsLeap Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT01772004 2021-12-20Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)EMD SeronoPhase 1 Completed1,756 enrolled 59 charts
NCT02222922 2020-12-17A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsPfizerPhase 1 Completed138 enrolled 98 charts
NCT03704467 2020-11-13Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian CancerEMD SeronoPhase 1 Completed3 enrolled 11 charts